This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

JAMA Oncology Author Interviews

By JAMA Network

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers.

  1. 1.
    Association of Measurable Residual Disease With Survival in Patients With Acute Myeloid Leukemia10/08/2020
    14:00
  2. 2.
    Survival and Adjuvant Chemotherapy in Early-Stage NSCLC With vs Without Clinicopathologic Features09/17/2020
    23:13
  3. 3.
    Tailoring Intensity of Surveillance for Prostate Cancer Based on Prediction of Risk Stability08/27/2020
    18:57
  4. 4.
    Presence of ctDNA and CTCs After Chemotherapy and Recurrence of Triple-Negative Breast Cancer07/09/2020
    13:28
  5. 5.
    Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults06/18/2020
    24:17
  6. 6.
    Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases06/04/2020
    15:24
  7. 7.
    Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer04/16/2020
    11:37
  8. 8.
    Durvalumab With or Without Tremelimumab vs Standard Chemotherapy for Metastatic NSCLC04/09/2020
    19:10
  1. 9.
    HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer02/13/2020
    11:43
  2. 10.
    Cost Transparency for Prostate Cancer Radiation Therapy at National Cancer Institute–Designated Cancer Centers01/16/2020
    12:22
  3. 11.
    Association Between BMI and Overall Survival in Advanced Non–Small Cell Lung Cancer12/26/2019
    16:45
  4. 12.
    The Role of Maintenance Strategies in Metastatic Colorectal Cancer12/19/2019
    10:38
  5. 13.
    Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer10/03/2019
    12:23
  6. 14.
    Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer09/12/2019
    14:40
  7. 15.
    Women’s Representation Among Lead Investigators of Clinical Trials in Oncology08/08/2019
    12:09
  8. 16.
    Five-Year Survival Among Patients With Advanced Skin, Renal, and Lung Cancer Treated With Nivolumab07/25/2019
    19:26
  9. 17.
    Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers06/27/2019
    15:50
  10. 18.
    Prognostic Potential of Circulating Tumor DNA Measurement in Nonmetastatic Colorectal Cancer05/09/2019
    14:02
  11. 19.
    Single-Fraction Stereotactic vs Multifraction Radiotherapy for Pain Relief in Patients With Nonspine Bone Metastases04/18/2019
    11:45
  12. 20.
    The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms03/21/2019
    13:51
  13. 21.
    Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer02/21/2019
    14:36
  14. 22.
    Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation01/10/2019
    14:52
  15. 23.
    Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal BMI12/06/2018
    14:49
  16. 24.
    Surgery vs Radiotherapy in the Management of Gleason Score 9-10 Prostate Cancer and the Risk of Mortality11/15/2018
    19:34
  17. 25.
    Analgesic Use and Risk of Ovarian Cancer in the Nurses’ Health Studies10/04/2018
    16:19
  18. 26.
    Hyperprogressive Disease in Patients With Advanced NSCLC Treated With PD-1/PD-L1 Inhibitors09/06/2018
    15:21
  19. 27.
    Maintenance Treatment and Survival in Patients With Myeloma08/09/2018
    10:40
  20. 28.
    Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Breast Cancer Screening07/05/2018
    12:10
  21. 29.
    Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade06/14/2018
    9:44
  22. 30.
    Outcomes of Multiple-Gene Sequencing After Diagnosis of Breast Cancer05/10/2018
    7:38
  23. 31.
    Association of Colon Cancer Survival With ACS Guideline Adherence04/12/2018
    16:41
  24. 32.
    Standard vs Dose-Escalated Radiotherapy in Medium-Risk Prostate Cancer03/15/2018
    9:43
  25. 33.
    Atezolizumab Monotherapy for Patients With Metastatic Urothelial Cancer02/08/2018
    8:52
  26. 34.
    Dietary Inflammatory Potential and Risk of Colorectal Cancer in Men and Women01/18/2018
    10:46
  27. 35.
    Preoperative vs Postoperative CEA and Colon Cancer Outcome12/21/2017
    5:41
  28. 36.
    Critical Lessons From High-Value Oncology Practices11/16/2017
    11:18
  29. 37.
    Prophylactic Surgery for Stage IV Small Intestinal Neuroendocrine Tumors10/19/2017
    7:46
  30. 38.
    Trends in Adult Cancer–Related Emergency Department Utilization08/31/2017
    11:50
  31. 39.
    Prevalence of Cancer in Li-Fraumeni Syndrome Cohort08/03/2017
    8:28
  32. 40.
    Breast Cancer Due to Non–BRCA1 and Non–BRCA2 Mutations in Ashkenazi Jewish Women07/20/2017
    7:42
  33. 41.
    Trends in Reoperation After Initial Lumpectomy for Breast Cancer06/05/2017
    12:57
  34. 42.
    Combined TMPRSS2:ERG and PCA3 RNA Testing for Detection of Prostate Cancer05/18/2017
    9:00
  35. 43.
    Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors04/27/2017
    14:46
  36. 44.
    Birth Outcomes Among Adolescent and Young Adult Cancer Survivors03/23/2017
    8:13
  37. 45.
    Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Trials02/16/2017
    6:19
  38. 46.
    Delayed Adjuvant Chemotherapy After Lung Cancer Surgery01/05/2017
    8:08
  39. 47.
    Global Burden of Cancer 201512/03/2016
    6:01
  40. 48.
    Comparison of Vaginal Testosterone Cream or Vaginal Ring11/10/2016
    17:25
  41. 49.
    Association Between Androgen Deprivation Therapy and Risk of Dementia10/13/2016
    5:58
  42. 50.
    Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer10/06/2016
    3:00
  43. 51.
    Prognostic Factors for Local Control in Breast Cancer With Boost vs No Boost09/08/2016
    7:46
  44. 52.
    ESR1 Mutations in Metastatic Breast Cancer08/11/2016
    6:18
  45. 53.
    Outcomes for Biomarker-Based Treatment Strategies in Refractory Malignant Neoplasms06/06/2016
    6:24
  46. 54.
    Physiologic Frailty in Hematopoietic Cell Transplantation Patients06/02/2016
    5:22
  47. 55.
    Lifestyle Associations With US Cancer Incidence and Mortality05/19/2016
    7:13
  48. 56.
    Neratinib vs Trastuzumab for Untreated Metastatic ERBB2-Positive Breast Cancer04/14/2016
    17:30
  49. 57.
    Prostate-Specific Antigen Screening and Selective Treatment03/24/2016
    10:05
  50. 58.
    Effect of Long-term Use of Aspirin on the Risk for Cancer03/03/2016
    3:52
  51. 59.
    BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer02/11/2016
    6:17
  52. 60.
    Molecular Profiling in Pediatric Tumors01/28/2016
    12:16
  53. 61.
    Delayed Initiation of Chemotherapy and Breast Cancer12/10/2015
    8:42
  54. 62.
    Erlotinib and the Risk of Oral Cancer11/05/2015
    11:33
  55. 63.
    Breast Tumor Characteristics and Biennial vs Annual Mammography10/20/2015
    4:32
  56. 64.
    Agent Orange Exposure and Monoclonal Gammopathy09/03/2015
    9:14
  57. 65.
    Differences in the Acute Toxic Effects of Breast Radiotherapy08/06/2015
    8:40
  58. 66.
    Trends in Advance Care Planning in Patients With Cancer07/09/2015
    5:39
  59. 67.
    Obesity and Postmenopausal Invasive Breast Cancer Risk06/11/2015
    11:41
  60. 68.
    The Global Burden of Cancer 201305/28/2015
    6:19
  61. 69.
    Chemoresistance After Consumption of Fish and Fish Oil04/02/2015
    8:30
  62. 70.
    21-Gene Recurrence Score Assay for Breast Cancer03/05/2015
    6:05
  63. 71.
    Hereditary Diffuse Gastric Cancer Syndrome02/12/2015
    10:29

Listen to JAMA Oncology Author Interviews now.

Listen to JAMA Oncology Author Interviews in full in the Spotify app